Zacks Investment ResearchThu, 18 Jun 2026 15:31:10 GMTICCC's Valuation Remains Premium: Is it Worth Overpaying for?ICCC-0.76%
Zacks Investment ResearchMon, 25 May 2026 14:46:12 GMTImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong DemandICCC-0.76%
Seeking AlphaFri, 15 May 2026 14:40:44 GMTImmuCell Corporation (ICCC) Q1 2026 Earnings Call TranscriptICCC-0.76%